Your browser doesn't support javascript.
loading
Biological and Clinical Implications of Sex-Specific Differences in Alzheimer's Disease.
Santiago, Jose A; Potashkin, Judith A.
Afiliación
  • Santiago JA; NeuroHub Analytics, LLC, Chicago, IL, USA.
  • Potashkin JA; Cellular and Molecular Pharmacology Department, Center for Neurodegenerative Diseases and Therapeutics, The Chicago Medical School, Rosalind Franklin University of Medicine and Science, North Chicago, IL, USA. judy.potashkin@rosalindfranklin.edu.
Handb Exp Pharmacol ; 282: 181-197, 2023.
Article en En | MEDLINE | ID: mdl-37460661
Mounting evidence indicates that the female sex is a risk factor for Alzheimer's disease (AD), the most common cause of dementia worldwide. Decades of research suggest that sex-specific differences in genetics, environmental factors, hormones, comorbidities, and brain structure and function may contribute to AD development. However, although significant progress has been made in uncovering specific genetic factors and biological pathways, the precise mechanisms underlying sex-biased differences are not fully characterized. Here, we review several lines of evidence, including epidemiological, clinical, and molecular studies addressing sex differences in AD. In addition, we discuss the challenges and future directions in advancing personalized treatments for AD.
Asunto(s)
Palabras clave

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Enfermedad de Alzheimer Tipo de estudio: Risk_factors_studies Límite: Female / Humans / Male Idioma: En Revista: Handb Exp Pharmacol Año: 2023 Tipo del documento: Article País de afiliación: Estados Unidos

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Enfermedad de Alzheimer Tipo de estudio: Risk_factors_studies Límite: Female / Humans / Male Idioma: En Revista: Handb Exp Pharmacol Año: 2023 Tipo del documento: Article País de afiliación: Estados Unidos
...